Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477031
2.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Cancer
; 130(9): 1673-1683, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198485
3.
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.
Int J Cancer
; 153(2): 389-398, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843260
4.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203067
5.
Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes.
Proc Natl Acad Sci U S A
; 117(44): 27528-27539, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067394
6.
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
Int J Cancer
; 150(2): 317-326, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520567
7.
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Cancer Immunol Immunother
; 68(6): 1037, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919028
8.
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Cancer Immunol Immunother
; 68(6): 1025-1035, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852622
9.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319872
10.
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
Eur J Nucl Med Mol Imaging
; 44(8): 1319-1327, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28421240
11.
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.
BMC Cancer
; 17(1): 649, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28915798
12.
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Prostate
; 76(1): 32-40, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390914
13.
Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node.
Cancer Immunol Immunother
; 65(4): 405-15, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26935057
14.
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Oncology
; 91(5): 267-273, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544669
15.
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
Int J Cancer
; 136(6): E760-72, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242736
16.
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Int J Cancer
; 136(1): 127-37, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832153
17.
Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
Curr Opin Oncol
; 27(6): 482-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352539
18.
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 15(7): 700-12, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831977
19.
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Cancer
; 120(7): 968-75, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382803
20.
Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Clin Nucl Med
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768063